Skip to main content
Erschienen in: Clinical Research in Cardiology 7/2012

01.07.2012 | Original Paper

Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study

verfasst von: Luca Cantarini, Orso Maria Lucherini, Antonio Brucato, Luca Barone, Davide Cumetti, Francesca Iacoponi, Donato Rigante, Giovanni Brambilla, Silvana Penco, Maria Giuseppina Brizi, Maria Cristina Patrosso, Guido Valesini, Bruno Frediani, Mauro Galeazzi, Rolando Cimaz, Giuseppe Paolazzi, Antonio Vitale, Massimo Imazio

Erschienen in: Clinical Research in Cardiology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The potential clinical expression of tumor necrosis factor receptor-associated periodic syndrome (TRAPS), in the form of idiopathic recurrent acute pericarditis (IRAP) has not been explored in the medical literature. The aim of this study was to evaluate the incidence of TRAPS mutations in patients with recurrent pericarditis and identify possible clues to TRAPS diagnosis.

Methods

Therefore, 131 consecutive Caucasian IRAP patients were investigated for mutations of the TRAPS gene and prospectively evaluated.

Results

Out of 131 patients, 8 (6.1%) carried a mutation in the TNFRSF1A gene. Compared with those without genetic mutations, patients with TRAPS mutations had more frequently a positive family history for pericarditis and periodic fever syndromes (p < 0.001), a higher mean number of recurrences after the first year (p < 0.001), on colchicine treatment (p < 0.001), and a higher need of immunosuppressive therapies (p < 0.001).

Conclusion

TRAPS is a cause of recurrent pericarditis in 6% of unselected cases with recurrent pericarditis. A positive family history for pericarditis or periodic fever syndromes, a poor response to colchicine, recurrences after the first year from the index attack or on colchicine treatment, as well as the need of immunosuppressive agents are clues of the possible presence of TNFRSF1A gene mutations in patients with recurrent pericarditis.
Literatur
1.
Zurück zum Zitat Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G et al (2008) Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 8:44–47PubMedCrossRef Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G et al (2008) Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 8:44–47PubMedCrossRef
2.
Zurück zum Zitat Dalla Pozza R, Hartl D, Bechtold S, Urschel S, Kozlik-Feldmann R, Pankuweit S et al (2007) Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol 96:168–175PubMedCrossRef Dalla Pozza R, Hartl D, Bechtold S, Urschel S, Kozlik-Feldmann R, Pankuweit S et al (2007) Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol 96:168–175PubMedCrossRef
3.
Zurück zum Zitat Sliwa K, Mocumbi AO (2010) Forgotten cardiovascular diseases in Africa. Clin Res Cardiol 99:65–74PubMedCrossRef Sliwa K, Mocumbi AO (2010) Forgotten cardiovascular diseases in Africa. Clin Res Cardiol 99:65–74PubMedCrossRef
4.
Zurück zum Zitat Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A et al (2006) Long-term outcomes in difficult to treat patients with recurrent pericarditis. Am J Cardiol 98:267–271PubMedCrossRef Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A et al (2006) Long-term outcomes in difficult to treat patients with recurrent pericarditis. Am J Cardiol 98:267–271PubMedCrossRef
5.
Zurück zum Zitat Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991PubMedCrossRef Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991PubMedCrossRef
6.
Zurück zum Zitat Rigante D (2009) Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit 15:RA179–RA187PubMed Rigante D (2009) Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit 15:RA179–RA187PubMed
7.
Zurück zum Zitat McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133–144PubMedCrossRef McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133–144PubMedCrossRef
8.
Zurück zum Zitat Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346PubMedCrossRef Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346PubMedCrossRef
9.
Zurück zum Zitat Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J, French Heraditary Recurrent Inflammatory Disorder Study Group. French Hereditary Recurrent Inflammatory Disorder Study Group (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181–2188PubMedCrossRef Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J, French Heraditary Recurrent Inflammatory Disorder Study Group. French Hereditary Recurrent Inflammatory Disorder Study Group (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181–2188PubMedCrossRef
10.
Zurück zum Zitat Ravet N, Rouaghe S, Dodé C, Bienvenu J, Stirnemann J, Lévy P et al (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65:1158–1162PubMedCrossRef Ravet N, Rouaghe S, Dodé C, Bienvenu J, Stirnemann J, Lévy P et al (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65:1158–1162PubMedCrossRef
11.
Zurück zum Zitat McDermott EM, Smillie DM, Powell RJ (1997) Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc 72:806–817PubMedCrossRef McDermott EM, Smillie DM, Powell RJ (1997) Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc 72:806–817PubMedCrossRef
12.
Zurück zum Zitat Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. Clin Exp Rheumatol 28:290–291PubMed Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. Clin Exp Rheumatol 28:290–291PubMed
13.
Zurück zum Zitat Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S et al (2009) Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 22:1051–1058PubMed Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S et al (2009) Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 22:1051–1058PubMed
14.
Zurück zum Zitat Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 28:405–407PubMed Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 28:405–407PubMed
15.
Zurück zum Zitat Cantarini L, Lucherini OM, Cimaz R, Galeazzi M (2010) Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol 28:802PubMed Cantarini L, Lucherini OM, Cimaz R, Galeazzi M (2010) Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol 28:802PubMed
16.
Zurück zum Zitat Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT et al (2010) Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol 23:701–707PubMed Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT et al (2010) Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol 23:701–707PubMed
17.
Zurück zum Zitat Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A et al (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739–2744PubMedCrossRef Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A et al (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739–2744PubMedCrossRef
18.
Zurück zum Zitat Imazio, Brucato, Cemina et al (2011) Colchicine for recurrent pericarditis (CORP). A randomized trial. Ann Intern Med 155:409–414 Imazio, Brucato, Cemina et al (2011) Colchicine for recurrent pericarditis (CORP). A randomized trial. Ann Intern Med 155:409–414
19.
Zurück zum Zitat Imazio M, Bobbio M, Cecchi E et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991PubMedCrossRef Imazio M, Bobbio M, Cecchi E et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991PubMedCrossRef
20.
Zurück zum Zitat Imazio Brucato (2009) Doria et al. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance. Int J Cardiol 136:289–293PubMedCrossRef Imazio Brucato (2009) Doria et al. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance. Int J Cardiol 136:289–293PubMedCrossRef
21.
Zurück zum Zitat Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010) Controversial issues in the management of pericardial diseases. Circulation 121:916–928PubMedCrossRef Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010) Controversial issues in the management of pericardial diseases. Circulation 121:916–928PubMedCrossRef
22.
Zurück zum Zitat Imazio M, Brucato A, Doria , Brambilla G, Ghirardello A, Romito A (2009) Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol 136:289–293PubMedCrossRef Imazio M, Brucato A, Doria  , Brambilla G, Ghirardello A, Romito A (2009) Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol 136:289–293PubMedCrossRef
23.
Zurück zum Zitat Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A et al (2010) Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96:779–784PubMedCrossRef Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A et al (2010) Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96:779–784PubMedCrossRef
24.
Zurück zum Zitat Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M (2010) Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev 9:9436–9440 Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M (2010) Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev 9:9436–9440
25.
Zurück zum Zitat Cantarini L, Imazio M, Brizi MG, Lucherini OM, Brucato A, Cimaz R, et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol 2010 [Epub ahead of print]. doi:10.1007/s12016-010-8219-x Cantarini L, Imazio M, Brizi MG, Lucherini OM, Brucato A, Cimaz R, et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol 2010 [Epub ahead of print]. doi:10.​1007/​s12016-010-8219-x
26.
Zurück zum Zitat Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M (2010) Serosal involvement in adult-onset autoinflammatory disorders. Respiration 80:260–261PubMedCrossRef Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M (2010) Serosal involvement in adult-onset autoinflammatory disorders. Respiration 80:260–261PubMedCrossRef
27.
Zurück zum Zitat Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A (2009) Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum 60:264–268PubMedCrossRef Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A (2009) Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum 60:264–268PubMedCrossRef
28.
Zurück zum Zitat Brucato A, Imazio M, Spodick D, Adler Y (2009) Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al. Arthritis Rheum 60:2543PubMedCrossRef Brucato A, Imazio M, Spodick D, Adler Y (2009) Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al. Arthritis Rheum 60:2543PubMedCrossRef
29.
Zurück zum Zitat Brucato A, Brambilla G (2005) Recurrent idiopathic pericarditis: familial occurrence. Int J Cardiol 102:529PubMedCrossRef Brucato A, Brambilla G (2005) Recurrent idiopathic pericarditis: familial occurrence. Int J Cardiol 102:529PubMedCrossRef
30.
Zurück zum Zitat Trost S, Rosé CD (2005) Myocarditis and sacroileitis. 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175–177PubMed Trost S, Rosé CD (2005) Myocarditis and sacroileitis. 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175–177PubMed
31.
Zurück zum Zitat D’Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F et al (2006) Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 54:998–1008PubMedCrossRef D’Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F et al (2006) Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 54:998–1008PubMedCrossRef
32.
Zurück zum Zitat Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCrossRef Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCrossRef
33.
Zurück zum Zitat Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM et al (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327PubMedCrossRef Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM et al (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327PubMedCrossRef
34.
Zurück zum Zitat Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef
35.
Zurück zum Zitat Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S, Zulian F et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63:1141–1150PubMedCrossRef Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S, Zulian F et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63:1141–1150PubMedCrossRef
36.
Zurück zum Zitat Soler–Soler J, Sagristà-Sauleda J, Permanyer-Miralda G (2004) Relapsing pericarditis. Heart 90:1364–1368PubMedCrossRef Soler–Soler J, Sagristà-Sauleda J, Permanyer-Miralda G (2004) Relapsing pericarditis. Heart 90:1364–1368PubMedCrossRef
37.
Zurück zum Zitat Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F et al (2005) Colchicine in addition to conventional therapy for acute pericarditis: results of the colchicine for acute pericarditis (COPE) trial. Circulation 112:2012–2016PubMedCrossRef Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F et al (2005) Colchicine in addition to conventional therapy for acute pericarditis: results of the colchicine for acute pericarditis (COPE) trial. Circulation 112:2012–2016PubMedCrossRef
38.
Zurück zum Zitat Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y et al (2004) Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 25:587–610PubMedCrossRef Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y et al (2004) Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 25:587–610PubMedCrossRef
Metadaten
Titel
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study
verfasst von
Luca Cantarini
Orso Maria Lucherini
Antonio Brucato
Luca Barone
Davide Cumetti
Francesca Iacoponi
Donato Rigante
Giovanni Brambilla
Silvana Penco
Maria Giuseppina Brizi
Maria Cristina Patrosso
Guido Valesini
Bruno Frediani
Mauro Galeazzi
Rolando Cimaz
Giuseppe Paolazzi
Antonio Vitale
Massimo Imazio
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 7/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0422-8

Weitere Artikel der Ausgabe 7/2012

Clinical Research in Cardiology 7/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.